PAVmed Funding: How Much Did They Raise & Key Investors

How Much Did PAVmed Raise?
Funding & Key Investors

PAVmed Inc. has solidified its position in the medical technology landscape with a significant capital injection, bringing its cumulative financing to $51.2M. This latest major strategic investment of $30M underscores the firm's ongoing commitment to scaling its diversified portfolio of medical devices and digital health solutions. By securing this substantial backing, the New York-based entity continues to demonstrate its capacity to attract institutional interest despite the volatile nature of the healthcare innovation sector.

The company's growth trajectory, marked by a series of debt and equity financing rounds, reflects a deliberate strategy to transition from early-stage development to a robust commercial-stage enterprise. This recent infusion of capital serves as a critical catalyst for accelerating the market penetration of its proprietary infusion pumps and vascular access technologies.

What is PAVmed?

PAVmed

Manufacturing

Medical Devices & Equipment

Founded in 2014, PAVmed operates as a multifaceted medical technology firm with a broad footprint across diagnostics, digital health, and specialized medical hardware. The company's product ecosystem includes disposable infusion systems, short-term catheters, and advanced tissue ablation devices. By integrating these diverse medical verticals, PAVmed addresses critical gaps in clinical care, positioning itself as a versatile player capable of navigating the complex regulatory and commercial requirements of the modern healthcare industry. Its market position is defined by a focus on high-utility, scalable medical devices that aim to improve patient outcomes while optimizing hospital operational efficiency.

How much funding has PAVmed raised?

PAVmed has raised a total of $51.1M across 4 funding rounds:

2019

Debt

$14M

2020

Debt

$150K

Other Financing Round

$7M

2026

Stock/Share Issuance

$30M

Debt (2019): $14M with participation from Maxim Group LLC

Debt (2020): $150K led by PPP

Other Financing Round (2020): $7M, investors not publicly disclosed

Stock/Share Issuance (2026): $30M, investors not publicly disclosed

Key Investors in PAVmed

Maxim Group LLC

A full-service investment bank providing financial advisory and capital raising services to emerging growth companies.

PPP

Public-Private Partnership

Undisclosed Investor

An institutional backer participating in the latest funding round to support the company's strategic expansion.

What's next for PAVmed?

With the successful closure of this major strategic investment, PAVmed is well-positioned to scale its commercial operations and expand its diagnostic and digital health offerings. The company is expected to prioritize the deployment of its capital toward R&D initiatives and the expansion of its sales infrastructure to support the broader adoption of its vascular access and ablation technologies. As the firm moves into this next phase of growth, stakeholders will likely monitor its ability to convert this liquidity into sustained revenue growth and market share expansion within the competitive medical device landscape. The strategic focus remains on leveraging its existing intellectual property to drive long-term value in the evolving digital health market.

See full PAVmed company page

See More Financial Insights